BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 30642367)

  • 1. Omalizumab in children with severe allergic disease: a case series.
    Crisafulli G; Caminiti L; Chiera F; Arasi S; Salzano G; Panasiti I; Barbalace A; Pajno GB
    Ital J Pediatr; 2019 Jan; 45(1):13. PubMed ID: 30642367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining anti-IgE with oral immunotherapy.
    Lin C; Lee IT; Sampath V; Dinakar C; DeKruyff RH; Schneider LC; Nadeau KC
    Pediatr Allergy Immunol; 2017 Nov; 28(7):619-627. PubMed ID: 28782296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of omalizumab in patients with food allergy.
    Rafi A; Do LT; Katz R; Sheinkopf LE; Simons CW; Klaustermeyer W
    Allergy Asthma Proc; 2010; 31(1):76-83. PubMed ID: 20167148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-IgE--emerging opportunities for Omalizumab.
    Babu KS; Polosa R; Morjaria JB
    Expert Opin Biol Ther; 2013 May; 13(5):765-77. PubMed ID: 23517576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omalizumab in children.
    Licari A; Marseglia A; Caimmi S; Castagnoli R; Foiadelli T; Barberi S; Marseglia GL
    Paediatr Drugs; 2014 Dec; 16(6):491-502. PubMed ID: 25404353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of omalizumab in allergen immunotherapy.
    Dantzer JA; Wood RA
    Clin Exp Allergy; 2018 Mar; 48(3):232-240. PubMed ID: 29315922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of omalizumab in the treatment of food allergy and anaphylaxis.
    Lieberman JA; Chehade M
    Curr Allergy Asthma Rep; 2013 Feb; 13(1):78-84. PubMed ID: 23065311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining Anti-IgE Monoclonal Antibodies and Oral Immunotherapy for the Treatment of Food Allergy.
    Guilleminault L; Michelet M; Reber LL
    Clin Rev Allergy Immunol; 2022 Feb; 62(1):216-231. PubMed ID: 34550555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy.
    Humbert M; Bousquet J; Bachert C; Palomares O; Pfister P; Kottakis I; Jaumont X; Thomsen SF; Papadopoulos NG
    J Allergy Clin Immunol Pract; 2019; 7(5):1418-1429. PubMed ID: 30928481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of anti-IgE therapy beyond allergic asthma.
    Stokes JR; Casale TB
    J Allergy Clin Immunol Pract; 2015; 3(2):162-6. PubMed ID: 25609342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgE-Related Chronic Diseases and Anti-IgE-Based Treatments.
    Navinés-Ferrer A; Serrano-Candelas E; Molina-Molina GJ; Martín M
    J Immunol Res; 2016; 2016():8163803. PubMed ID: 28097159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Off-Label Uses of Omalizumab.
    El-Qutob D
    Clin Rev Allergy Immunol; 2016 Feb; 50(1):84-96. PubMed ID: 26048266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omalizumab in children with uncontrolled allergic asthma: Review of clinical trial and real-world experience.
    Chipps BE; Lanier B; Milgrom H; Deschildre A; Hedlin G; Szefler SJ; Kattan M; Kianifard F; Ortiz B; Haselkorn T; Iqbal A; Rosén K; Trzaskoma B; Busse WW
    J Allergy Clin Immunol; 2017 May; 139(5):1431-1444. PubMed ID: 28477722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial.
    Andorf S; Purington N; Block WM; Long AJ; Tupa D; Brittain E; Rudman Spergel A; Desai M; Galli SJ; Nadeau KC; Chinthrajah RS
    Lancet Gastroenterol Hepatol; 2018 Feb; 3(2):85-94. PubMed ID: 29242014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omalizumab in the treatment of eosinophilic esophagitis and food allergy.
    Rocha R; Vitor AB; Trindade E; Lima R; Tavares M; Lopes J; Dias JA
    Eur J Pediatr; 2011 Nov; 170(11):1471-4. PubMed ID: 21809010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of severe asthma and peach allergy that improved with omalizumab therapy: a case report].
    Suzuki S; Matsuura T; Kimura T; Tazaki T; Fukuda M; Homma T; Matsukura S; Kurokawa M; Adachi M
    Arerugi; 2012 Feb; 61(2):215-23. PubMed ID: 22437731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omalizumab : other indications and unanswered questions.
    Mankad VS; Burks AW
    Clin Rev Allergy Immunol; 2005 Aug; 29(1):17-30. PubMed ID: 16222081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Immunotherapy for Food Allergy.
    Wood RA
    J Investig Allergol Clin Immunol; 2017; 27(3):151-159. PubMed ID: 28102823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral immunotherapy and potential treatment.
    Sato S; Yanagida N; Ebisawa M
    Chem Immunol Allergy; 2015; 101():106-13. PubMed ID: 26022870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omalizumab: Anti-IgE therapy in allergy.
    Kopp MV
    Curr Allergy Asthma Rep; 2011 Apr; 11(2):101-6. PubMed ID: 21243454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.